Webinars

Historically MSI has been used to screen for Lynch syndrome, a dominant hereditary cancer propensity. Since 2015, MSI status has been rediscovered as a biomarker for immunotherapeutic response, making MSI status an increasingly relevant tool for genetics and immuno-oncology applications. In this webinar, we will discuss MSI testing gold standards and compare the different methods that are currently being used for MSI testing for mismatch repair deficient (dMMR) tumors. We will also discuss the clinical relevance of the MSI-H biomarker focusing on the pathological and epidemiological characteristics of MSI-H/dMMR tumors, and the role of MSI testing in Lynch syndrome screening, colorectal cancer patient prognosis, and immunotherapy treatment. 

Automating your nucleic acid extraction workflows can enable higher throughput, improve precision, reduce labor, etc. However, developing the methods on highly flexible and sophisticated liquid handling platforms such as the Hamilton, Tecan, Beckman Coulter etc. is non-trivial and requires an understanding of the robotics, the biological sample, the extraction chemistry, and the quality requirements of the downstream application to assess the performance of the workflow. Developing workflows for the first time can take months depending on one’s experience and often problems can linger leading to difficulties for years if the method was not optimized. Learn more about how to efficiently automate your nucleic acid extraction workflow and ask our panel of experts all the challenging questions you have.